Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer

被引：0
|
作者：
Michele Moschetta
Gabriel Mak
Joana Hauser
Catriona Davies
Mario Uccello
Hendrik-Tobias Arkenau
机构：
[1] Sarah Cannon Research Institute,Drug Development Unit
[2] University College London,undefined
来源：
Experimental Hematology & Oncology | / 6卷
关键词：
Dabrafenib; Trametinib; BRAF V600E mutation; Microsatellite instability; Endometrial cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The clinical effect of concurrent oncogenic gene mutations in BRAF p.(V600E)-mutated NSCLC treated with dabrafenib and trametinib
    Meng, P.
    Koopman, B.
    Kok, K.
    ter Elst, A.
    Schuuring, E.
    van Kempen, L. C.
    Timens, W.
    Hiltermann, T. J. N.
    Groen, H. J. M.
    van den Berg, A.
    van der Wekken, A. J.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1106 - S1106
  • [22] Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation
    Ceccon, Garry
    Werner, Jan-Michael
    Dunkl, Veronika
    Tscherpel, Caroline
    Stoffels, Gabriele
    Brunn, Anna
    Deckert, Martina
    Fink, Gereon R.
    Galldiks, Norbert
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (04)
  • [23] Dabrafenib and trametinib in patients with metastatic BRAFV600E-mutated thyroid cancer
    Jeon, Y-K.
    Jung, H. A.
    Park, S.
    Lee, S-H.
    Kim, T. H.
    Kim, S. W.
    Chung, J. H.
    Ahn, M-J.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1299 - S1299
  • [24] Dramatic Therapeutic Response to Dabrafenib Plus Trametinib in BRAF V600E Mutated Papillary Craniopharyngiomas: A Case Report and Literature Review
    Fasano, Morena
    Della Corte, Carminia Maria
    Caterino, Marianna
    Pirozzi, Mario
    Rauso, Raffaele
    Troiani, Teresa
    Martini, Giulia
    Napolitano, Stefania
    Morgillo, Floriana
    Ciardiello, Fortunato
    [J]. FRONTIERS IN MEDICINE, 2022, 8
  • [25] Combination therapy of dabrafenib plus trametinib in patients with BRAF V600E-mutated biliary tract cancer
    Rizzo, Alessandro
    Ricci, Angela Dalia
    Brandi, Giovanni
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2021, 20 (05) : 506 - 507
  • [26] Rapid and dramatic responses to dabrafenib and trametinib in BRAF V600E-mutated lung adenocarcinoma
    Ota, Takayo
    Okabayashi, Aya
    Fukuoka, Masahiro
    [J]. RESPIROLOGY CASE REPORTS, 2021, 9 (10):
  • [27] Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease
    Burger, Michael C.
    Ronelenfitsch, Michael W.
    Lorenz, Nadja I.
    Wagner, Marlies
    Voss, Martin
    Capper, David
    Tzaridis, Theophilos
    Herlinger, Ulrich
    Steinbach, Joachim P.
    Stoffels, Gabriele
    Langen, Karl-Josef
    Brandts, Christian
    Senft, Christian
    Harter, Patrick N.
    Baehr, Oliver
    [J]. ONCOLOGY REPORTS, 2017, 38 (06) : 3291 - 3296
  • [28] THE IMPACT OF BRAF V600E MUTATION AND MICROSATELLITE INSTABILITY ON OVERALL SURVIVAL (OS) IN METASTATIC COLORECTAL CANCER (MCRC)
    Parikh, A.
    Li, B.
    Lamarre, N.
    Abraham, A.
    Parzynski, C.
    Vieira, M. C.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S463 - S463
  • [29] DABRAFENIB IN PATIENTS WITH RECURRENT, BRAF V600E MUTATED MALIGNANT GLIOMA AND LEPTOMENINGEAL DISEASE
    Burger, Michael
    Ronellenfitsch, Michael
    Lorenz, Nadja
    Wagner, Marlies
    Voss, Martin
    Capper, David
    Tzaridis, Theophilos
    Herrlinger, Ulrich
    Steinbach, Joachim
    Stoffels, Gabriele
    Langen, Karl-Josef
    Brandts, Christian
    Senft, Christian
    Harter, Patrick
    Baehr, Oliver
    [J]. NEURO-ONCOLOGY, 2017, 19 : 217 - 217
  • [30] Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma
    Giovanni Ponti
    Aldo Tomasi
    Giovanni Pellacani
    [J]. Journal of Hematology & Oncology, 5
12345